Upper Respiratory Tract Infection
An Upper Respiratory Tract Infection (URTI) is an acute illness caused by an infection of the upper respiratory tract, including the nose, sinuses, pharynx, larynx, or trachea, often leading to symptoms like nasal obstruction, sore throat, and inflammation. These infections are usually viral but can also be bacterial, fungal, or helminthic.
Health Outcomes
- Accelerated Recovery of B Cell-Mediated Respiratory Immunity
- Accelerated Recovery within 3 Days
- Blocked Pneumococcal Binding Sites
- Colonization of Nasopharynx or Adenoid Tissue
- Elevated Viable Bacterial Counts
- Enhanced Anti-Infective Properties
- Enhanced Early Immune Response
- Enhanced IgA Response
- Enhanced Immune System
- Enhanced Immunity to Pneumococcal Infections
- Enhanced Immunological Defense Against Respiratory Viral Infections
- Enhanced Innate Antiviral Immune Response
- Enhanced Mucosal Immune Function
- Enhanced Non-specific Immune Defense
- Enhanced Phagocytosis by Monocyte-Derived Dendritic Cells
- Enhanced Protection Against Infection
- Enhanced Protection Against Streptococcus Pyogenes Infection
- Enhanced Pulmonary Immune Response
- Enhanced Resistance to Infections
- Enhanced Resistance to Respiratory Infections
- Improved Airway Immune Response
- Improved Anti-infection Response
- Improved Clinical Protection Against Viral Challenge
- Improved Clinical Symptoms of Influenza
- Improved Control of Otitis Media
- Improved Defense Mechanism Recovery
- Improved Disease Resolution
- Improved Health Outcome Relative to Zinc Bacitracin
- Improved Health in Breastfed Infants
- Improved Humoral Immune Response
- Improved Immune Mechanisms Against S. pneumoniae
- Improved Immune Response to Adenovirus
- Improved Innate Immunity
- Improved Mucosal Immunity
- Improved Nasal Symptoms in Perennial Allergic Rhinitis
- Improved Pneumococcal Infection Outcomes
- Improved Resistance Against Respiratory Syncytial Virus
- Improved Resistance against Infections
- Improved Resistance to Common Cold
- Improved Resistance to Infections
- Improved Respiratory Humoral Response
- Improved Respiratory Immune Function
- Improved Respiratory Immunity
- Improved Respiratory Infection Resistance
- Improved Respiratory Innate Immune Response
- Improved Respiratory Mucosal Barrier Function
- Improved Respiratory Tract Health
- Improved Response
- Improved Serum Immunity
- Improved Symptom Resolution Rate
- Improved Vaccine-Specific Secretory IgA Levels in Saliva
- Increased Adhesion to Epithelia
- Increased Anti-Pneumococcal Antibody Levels
- Increased Anti-Viral Factor Expression in Lung
- Increased Antigen-Specific Immunoglobulin A
- Increased Body Temperature
- Increased Days Without Illness
- Increased Fever-Free Days
- Increased Incidence of Upper Respiratory Symptoms
- Increased Incidence of Upper Respiratory Tract Infections
- Increased Infection
- Increased Mucosal B-Cell Responses
- Increased Resistance to Pneumococcal Infections
- Increased Respiratory Burst Activity
- Increased URTI-Free Rate
- Induced Antigen-Specific Protective Mucosal Immune Response
- Maintained Higher Salivary Immunoglobulin A Levels
- Modulated Upper Airway Immune Response
- Modulation of Pulmonary Innate Immune Function
- Nasopharyngeal Colonization
- No Reduction in Antibiotic Use
- No Significant Reduction in URTI Incidence
- Prevented Upper Respiratory Tract Infection
- Reduced Acute Otitis Media
- Reduced Acute Pharyngotonsillitis
- Reduced Acute Respiratory Tract Infection Incidence
- Reduced Antibiotic Duration
- Reduced Antibiotic Usage
- Reduced Antibiotic and Antiviral Use
- Reduced Bloody Nasal Mucus
- Reduced Cervical Lymphadenopathy Frequency
- Reduced Cold/Flu Medication Use
- Reduced Cold/Flu Severity
- Reduced Common Cold Incidence in Susceptible Populations
- Reduced Community-Acquired Infection
- Reduced Community-Acquired Infection Incidence
- Reduced Cough Duration
- Reduced Day Care Absence
- Reduced Day Care Absenteeism Due to Infections
- Reduced Days with Runny Nose Symptoms
- Reduced Duration of Antipyretic Therapy
- Reduced Duration of Common Cold Symptoms
- Reduced Duration of Infectious Diseases
- Reduced Duration of Nasal Symptoms
- Reduced Duration of Respiratory Infection
- Reduced Duration of Respiratory Tract Infection Episode
- Reduced Duration of Respiratory Tract Infections
- Reduced Duration of URTI-Associated Symptoms
- Reduced Duration of Upper Respiratory Symptoms
- Reduced Duration of Upper Respiratory Tract Illness
- Reduced Duration of Upper Respiratory Tract Infection
- Reduced Episode Duration
- Reduced Exacerbation of Chronic Adenoiditis
- Reduced Febrile Flares
- Reduced Fever
- Reduced Fever Duration During CID
- Reduced Fever Incidence
- Reduced Frequency of Pharyngitis
- Reduced Frequency of Recurring Colds
- Reduced Frequency of Streptococcal Pharyngeal Infections
- Reduced Hoarseness
- Reduced Hoarseness Duration
- Reduced Immunosuppression in Pharyngitis
- Reduced Impact of Rhinovirus Infection
- Reduced Incidence of Cold/Flu Days
- Reduced Incidence of Colds
- Reduced Incidence of Common Cold
- Reduced Incidence of Common Infections
- Reduced Incidence of Community-Acquired Colds
- Reduced Incidence of Infections
- Reduced Incidence of Influenza-like Illness
- Reduced Incidence of Pharyngitis
- Reduced Incidence of Recurring Colds
- Reduced Incidence of Respiratory Illness
- Reduced Infant Infections
- Reduced Infant Wheeze
- Reduced Infection Incidence
- Reduced Infectious RV Titer
- Reduced Laryngitis
- Reduced Lung Viral Titers
- Reduced Mean Number of Infections per Child
- Reduced Nasal Colonization
- Reduced Nasal Congestion
- Reduced Nasal Symptom Score
- Reduced Nasal Symptoms
- Reduced Otitis Media Episode Incidence
- Reduced Pathogen Attachment
- Reduced Pathogen Growth
- Reduced Pathogen Incidence
- Reduced Pathogenic Colonies
- Reduced Postinfective Symptoms
- Reduced Potential Pathogens
- Reduced RSV Replication
- Reduced Respiratory Illness
- Reduced Respiratory Infections
- Reduced Respiratory Infections in Infants
- Reduced Respiratory Pathogen Load
- Reduced Respiratory Symptoms
- Reduced Respiratory Tract Infection Episode
- Reduced Respiratory Tract Infection Episodes
- Reduced Respiratory Tract Infections
- Reduced Rhinovirus Nasal Lavage Titer
- Reduced Risk of Prolonged Respiratory Infections
- Reduced School Absence Days
- Reduced School Absenteeism Due to Infectious Diseases
- Reduced Severity of Nasal Congestion and Runny Nose
- Reduced Severity of URTIs
- Reduced Sick Leave Days
- Reduced Sneezing Symptoms
- Reduced Sore Throat Duration
- Reduced Sore Throat Severity
- Reduced Symptom Duration
- Reduced Throat Symptom
- Reduced Time to Symptom Resolution
- Reduced URTI Duration
- Reduced URTI Symptoms
- Reduced Upper Respiratory Infection
- Reduced Upper Respiratory Infections
- Reduced Upper Respiratory Symptoms
- Reduced Upper Respiratory Tract Infection
- Reduced Upper Respiratory Tract Infection Days
- Reduced Upper Respiratory Tract Infection Duration
- Reduced Upper Respiratory Tract Infection Symptom Severity
- Reduced Upper Respiratory Tract Infection Symptoms
- Reduced Upper Respiratory Tract Infection Treatment Duration
- Reduced Use of URTI-Associated Medication
- Reduced Viral Respiratory Infection
- Reduced Virus Titers in Bronchoalveolar Lavage Fluid
- Restored Microbial Community Structure in Upper Respiratory Tract
- Shortened Treatment Course
- Unchanged Severity of URTI
- Upper Respiratory Tract Colonization